DrugDashboards

Market view

sodium phenylacetate and sodium benzoate · Injection, Solution, Concentrate

8 marketed package NDCs · 5 active manufacturers

Most dispensed: 100 mg/mL; 100 mg/mL · Injection, Solution, Concentrate · #1 vial, single-dose/carton / 50 ml in 1 vial, single-dose

The short version

5 companies supply this market — a reasonable cushion if one runs into trouble.

What changed in the last 90 days

Every detected change for sodium phenylacetate and sodium benzoate, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Nitrogen Binding Agent, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Sodium phenylacetate and sodium benzoate in shortage right now?
No. FDA does not currently list Sodium phenylacetate and sodium benzoate in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Sodium phenylacetate and sodium benzoate?
7 companies have marketed Sodium phenylacetate and sodium benzoate in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.